Light Chain Amyloidosis-Induced Autophagy Is Mediated by the Foxo3a/Beclin-1 Pathway in Cardiomyocytes
Overview
Affiliations
Cardiac amyloidosis is a disease in which the extracellular space of the heart is deposited with and infiltrated by amyloid fibrillar material, and light chain (LC) amyloidosis (AL) is the most serious form of the disease. AL is caused by the overproduction and aggregation of monoclonal immunoglobulin LCs produced by bone marrow plasma cells. Studies have shown that the initial response at a subcellular level to the toxicity of AL is lysosomal dysfunction with impaired autophagy, elevated reactive oxygen species, cellular dysfunction, and cellular death. Therefore, we speculate that the multiple myeloma complicated by cardiac amyloidosis is due to the deposition of λ LC fibrils in cardiomyocytes, leading to dysregulation of autophagy and cell death. We constructed BACN1 siRNA or FOXO3A siRNA and transfected them into H9c2 cells. We detected changes in oxidative stress- and autophagy-related markers. Our results show that monoclonal immunoglobulin λ LCs can form amyloid aggregates, which are cytotoxic to cardiomyocytes. λ LC fibrils deposit on the cell surface, causing oxidative stress and excessive autophagy by increasing Beclin-1 expression and the LC3 II/LC3 I ratio and decreasing p62 expression, ultimately inducing cell death. Beclin-1 knockdown reversed the increase in the LC3 II/LC3 I ratio and the decrease in p62 induced by LC fibrils, while suppressing overactivated autophagy and oxidative stress. Furthermore, LCs reduce the expression of p-Foxo3a (Ser253) (inactive) and promote Foxo3a translocation into the nucleus to perform transcriptional activity, which induces autophagy-related gene overexpression. Silencing Foxo3a can suppress excessive autophagy induced by LC fibrils and protect cells from death. In summary, the results showed that the cytotoxicity of amyloid fibrils formed by λ LCs on cardiomyocytes is triggered by excessive autophagy and is mediated through the Foxo3a/Beclin-1 pathway.
Hashemi M, Abolghasemi Fard A, Pakshad B, Asheghabadi P, Hosseinkhani A, Hosseini A Noncoding RNA Res. 2024; 11:1-21.
PMID: 39720352 PMC: 11665378. DOI: 10.1016/j.ncrna.2024.11.006.
Cheng M, Liu X, Wei Y, Xing X, Liu L, Xin N Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(10):1995-2003.
PMID: 39523100 PMC: 11526458. DOI: 10.12122/j.issn.1673-4254.2024.10.18.
Crosstalk between ubiquitin ligases and ncRNAs drives cardiovascular disease progression.
You J, Wen Z, Tian J, Lv X, Li R, Li S Front Immunol. 2024; 15:1335519.
PMID: 38515760 PMC: 10954775. DOI: 10.3389/fimmu.2024.1335519.
A proteomic atlas of kidney amyloidosis provides insights into disease pathogenesis.
Charalampous C, Dasari S, McPhail E, Theis J, Vrana J, Dispenzieri A Kidney Int. 2023; 105(3):484-495.
PMID: 38096952 PMC: 10922603. DOI: 10.1016/j.kint.2023.11.023.
Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications.
Liu Y, Ding W, Wang J, Ao X, Xue J Front Oncol. 2023; 13:1256537.
PMID: 37746261 PMC: 10514911. DOI: 10.3389/fonc.2023.1256537.